Dermatology clinical trials

About us 

The Alfred's dermatology department is a large tertiary referral centre for adults with all inflammatory and genetic skin conditions, as well as non-melanoma skin cancers. 

The unit is focused on new treatments for common conditions such as eczema and psoriasis as well as advancements in the treatment of more rare conditions such as vitiligo, hidradenitis suppurativa, bullous pemphigoid and urticaria. 

Our vision 

To advance the development of new treatments for acute severe and chronic on-going skin conditions. We want to improve the quality of life for patients with skin disease and bring more awareness to common and rarer skin conditions.

ClinTrial Refer website

Are you interested in our clinical trials?

ClinTrial Refer is a quick way to see all of our open trials, in one place. It’s the easy way to find a trial that may be right for you or your patient.

Find Dermatology clinical trials clinical trials on ClinTrial Refer

Our focus

We currently have trials for the following, but not limited to dermatological conditions:

  • Atopic Dermatitis (eczema)
  • Psoriasis
  • Hidradenitis suppurativa / Acne Inversa
  • Urticaria (CSU / CINDU)
  • Prurigo Nodularis
  • Immunobullous diseases (bullous pemphigoid etc...)
  • Ulcerative pyoderma gangrenosum
  • Vitiligo

What are Phase I, II, III or IV clinical trials?

There are four different phases of a clinical trial. Each phase is represented by a roman numeral.

Find out more about what happens in each phase

Our Team

Prof Johannes S Kern

Johannes is a conjoint Professor and Director of Dermatology, Monash University School of Translational Medicine and Alfred Health and Co-Head of the Monash University SkIIN Discovery Program.

Find out more
A/Prof Sue Yen Michelle Goh

A/Prof Michelle Goh is a Fellow of the Australasian College of Dermatologists (FACD).

Find out more
Dr Charlotte Krones

Charlotte, our Clinic and Trials Fellow, is a strong patient advocate and has a strong emphasis on patient-centred care.

Find out more
Melissa Markos

Melissa Markos is a Registered Nurse with an interest in research to improve treatment options.

Find out more
Frances Burns

Frances Burns is a Registered Nurse with a strong interest in research and improving participants' quality of life.

Find out more

Publications

Informing a position statement on the use of artificial intelligence in dermatology in Australia

Caffery LJ, Janda M, Miller R, Abbott LM, Arnold C, Caccetta T, Guitera P, Shumack S, Fernández-Peñas P, Mar V, Soyer HP

(2023), Australasian journal of dermatology, 64(1), e11-20

DOI: 10.1111/ajd.13946

Cancer Treatment Patterns and Factors Affecting Receipt of Treatment in Older Adults: Results from the ASPREE Cancer Treatment Substudy (ACTS)

Muhandiramge J, Warner ET, Zalcberg JR, Haydon A, Polekhina G, van Londen GJ, Gibbs P, Bernstein WB, Tie J, Millar JL, Mar VJ, McNeil JJ, Woods RL, Orchard SG; ASPREE Investigator Group

(2023), Cancers, 15(4), 1017

DOI: 10.3390/cancers15041017

CSL324, a granulocyte colony-stimulating factor receptor antagonist, blocks neutrophil migration markers that are upregulated in hidradenitis suppurativa

Gamell, Cristina; Bankovacki, Alexandra; Scalzo-Inguanti, Karen; Sedgmen, Bradley J; Alhamdoosh, Monther; Gail, Emma; Turkovic, Lydia; Millar, Christine; Johnson, Laura; Wahlsten, Michelle; Richter, Jim; Schuster, Jared; Dyson, Allison; Nicolopoulos, Jenn

(2023), British Journal of Dermatology, 188(5), 636-648

DOI: 10.1093/bjd/ljad013

View all publications for Dermatology clinical trials
News & articles
from Alfred Health
Read latest news